3950 JOHNS CREEK COURT, SUWANEE, GA
Market cap: $25.4M (12/18/2025)
Price: $0.86
Innovative Single-Device Solution Integrates Proven FemVue and FemChec® Technologies to Support Fallopian Tube Evaluation and Improve Workflow Efficiency
Continued Rollout of FemBloc, the Breakthrough Non-Surgical Permanent Contraceptive Solution, Expands Presence in Key European Markets
Femasys Inc. Enters into Securities Purchase Agreement with Investors
Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval
Notice of Delisting from Nasdaq Due to Market Value Shortfall
Changes in Board, Management or Compensation
News, Underwriting Agreement, Securities Holder Rights or Indentures
Advances European commercialization strategy following CE mark approval
Q2
Q1
FY 2024
Q3
FY 2023 amended
FY 2023
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Amended Registration Statement for Securities
S-1
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload